Determination of fluocortolone pivalate and fluocortolone hexanoate in suppositories using reverse-phase HPLC

Citation
O. Cudina et al., Determination of fluocortolone pivalate and fluocortolone hexanoate in suppositories using reverse-phase HPLC, FARMACO, 55(2), 2000, pp. 125-127
Citations number
9
Categorie Soggetti
Pharmacology & Toxicology
Journal title
FARMACO
ISSN journal
0014827X → ACNP
Volume
55
Issue
2
Year of publication
2000
Pages
125 - 127
Database
ISI
SICI code
0014-827X(200002)55:2<125:DOFPAF>2.0.ZU;2-X
Abstract
Fluocortolone and its esters are synthetic corticosteroids used topically i n the treatment of various skin disorders. A method that can be successfull y used for the separation and determination of fluocortolone pivalate and f luocortolone hexanoate in suppositories was developed. This method is based on reverse-phase HPLC on Supelcosil LC-18 (25 cm x 4.6 mm, 5 mu m), using methanol-acetonitrile-water-glacial acetic acid (17: 46:37:0.4 v/v/v/v) as mobile phase at a flow rate of 3.0 ml/min. Detection was carried out using a UV detector at 238 nm. The method developed was validated, and calibratio n curves were established dependent on peak area. The validated ranges for fluocortolone pivalate and fluocortolone hexanoate are 15-305 mu g/ml (r = 0.9995) and 15-315 mu g/ml (r = 0.9996), respectively. The limits of detect ion and the limits of quantification for both eaters were also determined. (C) 2000 Elsevier Science S.A. All rights reserved.